Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorates the Effect of Combined Oral Contraceptives (Cos)-Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats: A Recent Study
2022Book Publisher International (a part of SCIENCEDOMAIN International)Book Chapter
10.9734/bpi/nhmmr/v12/6111fFull text0 citations